Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide medications like Ozempic have demonstrated 15-22% body weight reduction in clinical trials, making them powerful tools for sustainable weight management. As more people explore adjunctive therapies to maximize results, questions arise about combining GLP-1 receptor agonists with other supplements—particularly NAD (nicotinamide adenine dinucleotide). Understanding the safety profile and potential synergies between these approaches helps you make informed decisions about your treatment plan.

Understanding NAD Supplementation and Semaglutide Interaction

NAD is a coenzyme found in every living cell that supports energy production, DNA repair, and metabolic function. Semaglutide works through a completely different mechanism—it activates GLP-1 receptors in the brain and pancreas to regulate appetite and blood sugar. Because these compounds target distinct biological pathways, direct pharmacological interactions are unlikely. However, individual metabolism varies based on genetic factors, liver function, and baseline nutrient status.

Taking NAD alongside semaglutide has not been extensively studied in controlled clinical trials, which means safety data remains limited rather than established as unsafe. Some patients report subjective improvements in energy or recovery when combining both approaches, but robust evidence specifically measuring this combination in weight loss studies is unavailable. PlexusDx recommends discussing any supplementation plan with your healthcare provider before starting, especially if you have liver disease, kidney concerns, or take other medications that affect NAD metabolism.

Potential Metabolic Synergies Between NAD and GLP-1 Therapy

NAD supports mitochondrial function and cellular energy efficiency, which theoretical research suggests could complement semaglutide's metabolic benefits. Semaglutide improves insulin sensitivity and reduces inflammation markers, while NAD is involved in sirtuins—proteins linked to aging, metabolic health, and longevity pathways. Together, they might theoretically enhance metabolic flexibility, though this remains speculative without human trials comparing the combination to semaglutide alone.

Weight loss itself increases NAD-dependent processes as your body mobilizes stored energy and rebuilds tissues. Rather than viewing NAD as a weight loss accelerator, it may function as a metabolic supporter during the intensive changes triggered by GLP-1 therapy. Lifestyle factors—sleep quality, resistance training, and nutrient density—typically produce far greater measurable impacts on weight loss velocity than NAD supplementation alone.

Safety Considerations and Medication Interactions

NAD precursors (nicotinamide riboside, NR; and nicotinamide mononucleotide, NMN) are generally well-tolerated at standard doses of 250-1000 mg daily. Semaglutide itself has a robust safety profile with side effects primarily gastrointestinal—nausea, vomiting, constipation—that improve as your body adapts. Combining them does not appear to elevate risk, but certain populations require caution: pregnant women should avoid GLP-1 therapy entirely, while those with personal or family history of medullary thyroid cancer or MEN-2 syndrome cannot use semaglutide regardless of NAD use.

Patients with liver disease should consult their physician before NAD supplementation, as high-dose nicotinamide can affect liver enzymes. Similarly, those taking niacin (vitamin B3) for cholesterol management risk overlapping effects if NAD precursors are added simultaneously. PlexusDx compounded semaglutide injections are prepared by licensed 503A pharmacies and require medical oversight through our provider network, ensuring your full supplement history is reviewed before therapy initiation.

Optimizing Weight Loss: Genetics, Personalization, and Evidence-Based Choices

Not all patients respond identically to semaglutide—genetic variation in GLP-1 receptor structure, GIPR signaling, and FTO gene expression influence both weight loss magnitude and side effect tolerance. PlexusDx Precision Peptide Genetic Test examines key variants like GLP1R rs6923761 and GIPR rs1800437 to map 14 pathways and 49 peptides, revealing which GLP-1 or dual-peptide approaches (semaglutide, tirzepatide, or GLP-Squared) align with your biology. This genetic insight often matters far more than supplement stacking for predicting individual success.

Rather than adding NAD on speculation, evidence-based optimization focuses on semaglutide dosing titration, exercise programming, and dietary protein intake—all proven to amplify results. PlexusDx Compounded Semaglutide Injection starts at $149/mo with flat pricing across dose increases, removing financial barriers to reaching your optimal therapeutic dose. If you want to explore additional supplements, discuss choices with your PlexusDx provider who can integrate that information into your personalized treatment protocol.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I safely take NAD supplements while using Ozempic or semaglutide?

NAD precursors like NR and NMN appear safe alongside semaglutide based on their distinct mechanisms, though controlled studies combining both are limited. Always disclose all supplements to your healthcare provider before starting GLP-1 therapy. PlexusDx medical teams review your full medication and supplement history during initial consultation to ensure safety.

Will adding NAD help me lose weight faster on semaglutide?

Clinical evidence does not demonstrate that NAD supplementation accelerates semaglutide-driven weight loss. Studies show semaglutide produces 15-22% body weight reduction on its own; adding NAD has not proven to increase this further in randomized trials. Optimizing semaglutide dose, exercise, and nutrition typically yields far greater results than supplement combinations.

Does PlexusDx offer NAD alongside compounded semaglutide?

PlexusDx specializes in compounded GLP-1 therapies from licensed 503A pharmacies, not supplementary NAD products. PlexusDx Compounded Semaglutide Injection starts at $149/mo with flat pricing regardless of dose level. Your provider can advise on NAD use independently, but PlexusDx focuses on precision GLP-1 and peptide-based approaches.

Are there risks combining NAD with semaglutide if I have liver disease?

Patients with liver disease should exercise caution with high-dose NAD supplementation, as it undergoes hepatic metabolism. Semaglutide itself requires careful dosing in liver disease and is contraindicated in severe cirrhosis. Any combination requires individualized medical assessment; PlexusDx providers screen for organ function before initiating therapy.

How can I know if NAD or semaglutide is right for my metabolism?

PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R to predict your GLP-1 responsiveness and optimal peptide choice. This genetic insight guides whether standard semaglutide, tirzepatide, or GLP-Squared best matches your biology—a more precise strategy than supplement guessing.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves